摘要
目的:利用EQ-5D量表评价和分析社区居民健康相关生命质量,并探究慢病数量对健康相关生命质量的影响。方法:基于我国EQ-5D效用值积分体系,运用Tobit回归、秩和检验等统计学方法进行影响因素分析。结果:居民在疼痛/不舒服维度存在问题的比例最高,不同慢病数量组间生命质量存在差异。结论:随着慢病数量的增加,居民在各维度存在健康问题的比例更大,健康相关生命质量更差。
Objective: To use EQ-5D scale to evaluate and analyze the health-related quality of life(HRQoL) of residents, and to explore the effect of the number of chronic diseases on HRQoL. Methods: Based on the EQ-5D utility score system in China, the Tobit regression model, rank-sum test and other statistical methods were employed to explore the influence factors. Results: Residents had the highest proportion of problems in the pain/discomfort dimension. There were differences in quality of life among groups with different numbers of chronic diseases. Conclusion: As the number of chronic diseases increased, residents were more likely to have health problems with worse HRQoL.
引文
[1]VAN DEN AKKER M,BUNTINX F,KNOTTNERUS JComorbidity or multimorbidity what’s in a name?A review of literature[J].European journal of general practice,1996,2(2):65-70.
[2]VALDERAS J M,STARFIELD B,SIBBALD B,et al.Defining comorbidity:implications for understanding health and health services[J].Annals of family medicine,2009,7(4):357-363.
[3]田诗音,陈琪,王睿,等.上海市老年人健康相关生命质量及其影响因素[J].中国公共卫生,2018(4):2-4.
[4]陈黄慧,刘蓉,巢健茜,等.南京市老年人生命质量及影响因素[J].中国老年学杂志,2016,36(4):955-956.
[5]周忠良,周志英,厉旦,等.陕西省城乡居民健康相关生命质量研究:基于EQ-5D量表效用值的测算[J].中国卫生经济,2015,34(2):13-16.
[6]官海静,刘国恩.中国四地城乡居民生命质量的比较分析[J].中国卫生经济,2015,34(2):5-12.
[7]K?NIG H,BERNERT S,ANGERMEYER M C,et al Comparison of population health status in six European countries:results of a representative survey using the EQ-5Dquestionnaire[J].Medical care,2009,47(2):255-261.
[8]李明晖,罗南.欧洲五维健康量表(EQ-5D)中文版应用介绍[J].中国药物经济学,2009(1):49-57.
[9]SULLIVAN P W,GHUSHCHYAN V H.EQ-5D scores for diabetes-related comorbidities[J].Value in health the journal of the international society for pharmacoeconomics&outcomes research,2016,19(8):1002-1008.
[10]王平平,李晶华,孔璇,等.吉林省城乡慢性病患者健康相关生命质量及影响因素分析[J].医学与社会,2015(11):54-57.
[11]邓明,张歆,谢欣,等.基于EQ-5D效用值积分体系的老年人自评健康状况研究[J].中国卫生经济,2016,35(12):18-20.